Tiffany joined the BHL in May 2021 as a Master’s student in Pharmaceutical Sciences to work on the role of NOX2 as a new drug target in Alzheimer’s disease to repair blood-brain barrier dysfunction. Tiffany successfully defended and will graduate with a dual PharmD/MS degree on May 3. Congratulations, Tiffany!

Brayden featured in UKNow for CURE Fellowship
UKNow recently featured Brayden’s selection for the 2026 Commonwealth Undergraduate Research Experience (CURE) Fellowship program. As part of the fellowship, Brayden will conduct summer research in the BHL and present his work at the Summer Research Symposium on August 25. You can read the full story HERE.


